Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Thoracic CT, CTPA and lung ultrasound

Respiratory · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Imaging must not postpone treatment of an immediately life-threatening clinical diagnosis such as tension pneumothorax or profound airway compromise. In suspected high-risk pulmonary embolism with shock, major haemoptysis, rapidly progressive hypoxaemia or a post-procedural collapse, resuscitate, involve senior clinicians and radiology early, and choose the fastest investigation that can safely change treatment. Local contrast, pregnancy and out-of-hours pathways apply.

Synopsis

Select and interpret thoracic CT, CT pulmonary angiography and lung ultrasound according to a precise clinical question, recognising each modality's urgent uses, limitations, harms and follow-up responsibilities.

  • Start with the question, not the scanner: non-contrast CT, contrast-enhanced CT, thin-section inspiratory and expiratory CT, CTPA and limited follow-up CT are different examinations with different timing and preparation.
  • CTPA is justified through clinical assessment of pulmonary-embolism probability and the recommended D-dimer or imaging pathway; it is not a screening test for unexplained breathlessness without risk stratification.
  • Confirm current renal information when indicated, previous iodinated-contrast reactions, pregnancy possibility, vascular access and the patient's ability to cooperate before contrast CT, then follow local radiology policy.
  • A technically limited or negative CTPA should be interpreted against pre-test probability and alternative diagnoses; persistent discordance requires radiology and senior clinical review rather than reflex reassurance.
  • Lung ultrasound is strong for pleural fluid, procedure guidance, peripheral consolidation and rapid pneumothorax assessment, but aerated lung and bone prevent complete visualisation of central thoracic pathology.
  • Absent lung sliding is not specific for pneumothorax, and B-lines are not specific for cardiogenic oedema; combine multiple signs, scan distribution, physiology and clinical context.
  • Incidental nodules, coronary calcification, emphysema, fibrosis and adrenal or upper-abdominal findings require explicit review and a named follow-up owner; the acute indication does not erase incidental responsibility.
  • Use the lowest justified radiation burden and avoid repeat imaging that cannot change management. Pregnancy and breastfeeding require informed protocol discussion, not automatic denial of necessary imaging.
  • Protocol names, contrast checks, point-of-care ultrasound credentialling and reporting escalation differ between UK services, so clinicians must follow local radiology governance.

Key red flags

Pulmonary arterial filling defect

A contrast filling defect within an adequately opacified pulmonary artery supports acute embolism; chronic embolic disease may show eccentric organised material, webs, vessel narrowing and mosaic perfusion. Right-heart strain features alter urgency but must be integrated with haemodynamics and formal reporting.

Non-diagnostic CTPA

Poor pulmonary-artery enhancement, respiratory motion, streak artefact or suboptimal coverage can prevent reliable exclusion of embolism. The report should state the limitation; subsequent imaging or management depends on clinical probability, bleeding risk and available alternatives.

Ultrasound pneumothorax signs

Loss of pleural sliding and B-lines with a barcode pattern on M-mode can support pneumothorax, and a lung point is more specific when present. Apnoea, pleurodesis, severe emphysema, mainstem intubation and adhesions can also abolish sliding, so physiology and expertise matter.

Investigation priorities

01
Clinical probability and D-dimerFirst step

Determine whether suspected pulmonary embolism needs CTPA or alternative imaging under the current diagnostic pathway.

Management branches

Protocol selectionConvert concern into a question

A patient may need thoracic CT but the optimal protocol is not yet defined.

  1. State the leading diagnostic question, urgency and the management decision that a positive or negative scan will change.
  2. Provide relevant history, examination, physiology, previous imaging, cancer or thromboembolic risk, renal and contrast information, and pregnancy possibility where relevant.
  3. Discuss protocol with radiology when the request could require CTPA, arterial phase, thin-section, expiratory, prone or image-guided techniques rather than selecting a generic label.
  4. Confirm who will review the authorised report, communicate urgent findings and action incidental or follow-up recommendations.
Open full textbook →Answer 2 questions
Sources and review status6 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • NICE NG158 venous thromboembolic diseasesProbability-led investigation, CTPA and interim management for suspected pulmonary embolism.
  • Royal College of Radiologists iRefer guidelinesUK professional framework for selecting and justifying diagnostic imaging.
  • Royal College of Radiologists CTPA audit templateAppropriateness and diagnostic-yield governance for CTPA use.
  • British Thoracic Society pleural procedures statementThoracic-ultrasound competencies, image guidance and pleural procedural safety.
  • RCR and SoR breastfeeding contrast statementUK professional advice on breastfeeding after iodinated CT or gadolinium MRI contrast.
  • GOV.UK IRMER guidanceStatutory guidance on justification, optimisation and responsibilities for medical radiation exposure.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. ·

Report a content problem
Content changes
Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom